NCT02785705View on ClinicalTrials.gov

Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

poliovirus vaccine

Different vaccination schedules with bOPV, tOPV and cIPV would be provided for 6 arms respectively.

All Listed Sponsors
collaborator

Air Force Military Medical University, China

OTHER

collaborator

Beijing Tiantan Biological Products Co., Ltd.

INDUSTRY

lead

Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control

OTHER_GOV

NCT02785705 - Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine | Biotech Hunter | Biotech Hunter